Our study highlights the importance of TMBIM1 in shaping the immune landscape of pancreatic cancer, demonstrating that its inhibition promotes CD8+ T-cell infiltration while reducing MDSC accumulation, thereby enhancing the effectiveness of PD-1 blockade. Here, TMBIM1 is linked to familial pancreatic carcinoma.